Tuesday, July 28, 2020 6:33:09 PM
Recent BCRX News
- BioCryst to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 11/06/2024 12:00:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2024 10:19:10 PM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/05/2024 12:00:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 12:06:59 PM
- BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/04/2024 12:00:00 PM
- BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat) • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- BioCryst to Report Third Quarter 2024 Financial Results on November 4 • GlobeNewswire Inc. • 10/21/2024 11:00:23 AM
- BioCryst to Present New Real-World Evidence Showing Significant Reductions in Medical Visits and Hospitalizations After Starting ORLADEYO® (berotralstat) • GlobeNewswire Inc. • 10/14/2024 11:00:00 AM
- BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting • GlobeNewswire Inc. • 10/10/2024 11:00:00 AM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 10/03/2024 11:00:53 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 11:06:38 AM
- BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome • GlobeNewswire Inc. • 10/02/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 11:11:26 AM
- U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir injection) Contract for Strategic National Stockpile • GlobeNewswire Inc. • 09/30/2024 11:00:00 AM
- BioCryst and the pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for ORLADEYO® (berotralstat), an Oral, Once-daily Therapy for the Prevention of Hereditary Angioedema Attacks • GlobeNewswire Inc. • 09/17/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 09/10/2024 04:09:00 PM
- BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium • GlobeNewswire Inc. • 09/06/2024 06:00:11 AM
- BioCryst Appoints Dr. Donald Fong Chief Medical Officer • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/04/2024 11:00:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:17:53 PM
- BioCryst to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 08/22/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:38:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 11:05:05 AM
- BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/05/2024 11:00:24 AM
- U.S. Index Futures and Oil Prices Plunge on Recession Concerns • IH Market News • 08/05/2024 09:46:20 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM